10:42 AM EDT, 06/16/2025 (MT Newswires) -- Crescent Biopharma (CBIO) said Monday it has completed its merger with GlycoMimetics ( CBIO ).

The combined business will operate as Crescent Biopharma and started trading on the Nasdaq on Monday.

Crescent said it completed a $200 million private financing, with investors including Fairmount and Venrock Healthcare Capital. It expects the proceeds to help support its operations through 2027.

Price: 18.00, Change: +2.30, Percent Change: +14.65